Sysmex enters into licensing agreement with Human Metabolome Technologies on depression biomarker

The biomarker is phosphoric acid ethanol amine (PEA) as a biomarker candidates for major depression, as discovered by HMT in cooperation with the National Center of Neurology and Psychiatry.

Nikkei Biotech news release, Sept. 29, 2015

Sysmex enters into licensing agreement with Human Metabolome Technologies on depression biomarker
Scroll to top